The Bulletin
The Times


.

Syneron Bio Announces Strategic Collaboration with AstraZeneca

  • Written by PR Newswire

BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader AstraZeneca to develop potential first-in-class macrocyclic peptides for the treatment of chronic diseases. Under this...

hacklink esim balkanzlibraryzlibraryz-libraryFanatikbetjojobethacklink panelmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopbahis casino siteleri